why it is important to use iv fluid when using dopamine in shock treatment
Reading File
Finding Sources
Finding Sources
Searching PubMed
dopamine vasopressor fluid resuscitation shock
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, authoritative content. Here is a thorough answer:
Why IV Fluid is Essential When Using Dopamine in Shock
The Core Principle: Vasopressors Require Adequate Preload
Dopamine (and all vasopressors) increase afterload — the resistance the heart must pump against. If the circulating blood volume is depleted, vasopressors cannot generate effective cardiac output because there is insufficient preload (venous return) to fill the heart. Pumping against high resistance with an empty tank worsens cardiac output rather than improving it.
Goldman-Cecil Medicine states this directly:
"Vasopressors increase afterload, so adequate hydration is important to optimize their effects. Vasopressors may have to be started concomitantly with fluid resuscitation, and they often can be reduced after adequate fluid resuscitation." — Goldman-Cecil Medicine, p. 1078
Dopamine's Mechanism Is Volume-Dependent
Dopamine acts in a dose-dependent fashion on α₁, β₁, and dopaminergic receptors:
| Dose | Dominant Effect |
|---|---|
| 1–5 µg/kg/min | Dopaminergic — renal/splanchnic vasodilation |
| 5–10 µg/kg/min | β₁ — ↑ HR, cardiac contractility, cardiac output |
| >10 µg/kg/min | α₁ — vasoconstriction, ↑ BP, ↑ SVR |
For dopamine to raise blood pressure and improve perfusion, the heart must have enough volume to eject. Without IV fluid replacement, especially in hypovolemic or distributive shock, dopamine's vasoconstrictive and inotropic effects will simply compress an under-filled heart and peripheral vasculature — producing inadequate flow to vital organs.
Tintinalli's Emergency Medicine specifically notes that dopamine is indicated when fluid resuscitation is unsuccessful or inappropriate, implying fluid resuscitation must be attempted first:
"Dopamine is indicated for reversing hemodynamically significant hypotension... when fluid resuscitation is unsuccessful or inappropriate." — Tintinalli's Emergency Medicine, p. 175
Key Physiological Reasons IV Fluid is Required
-
Restores circulating volume (preload): Shock, especially septic and hypovolemic shock, involves profound intravascular volume depletion. IV fluids fill the venous reservoir, allowing dopamine to generate a meaningful increase in cardiac output via the Frank-Starling mechanism.
-
Prevents tissue ischemia from vasopressor-only treatment: Using dopamine without fluid can divert blood from peripheral tissues to maintain central BP, causing gut ischemia, limb ischemia, and worsening lactic acidosis. Goldman-Cecil warns: "All vasopressors increase afterload, thereby potentially worsening cardiac failure, and can cause severe vasoconstriction, thereby leading to worsening acidosis and ischemia of the gut or limb."
-
Fluid resuscitation may eliminate the need for high vasopressor doses: After adequate volume replacement, vasopressors are often reduced or weaned — demonstrating that fluid directly addresses the underlying deficit that dopamine only compensates for pharmacologically.
-
Dilution and safe drug delivery: Dopamine is only given as an IV infusion and must be diluted in compatible IV fluid (e.g., D5W or NS) for safe administration. It cannot be given as a bolus or undiluted.
Practical Sequence in Septic/Distributive Shock
The Surviving Sepsis Campaign (reflected in Schwartz's Surgery and Goldman-Cecil) recommends:
- At least 30 mL/kg IV crystalloid within the first 3 hours of sepsis-induced hypoperfusion
- Start vasopressor (norepinephrine preferred over dopamine) if hypotension persists despite adequate fluid loading or if MAP <65 mmHg threatens perfusion
- Reassess fluid responsiveness before escalating vasopressor doses
"Vasopressors may have to be started concomitantly with fluid resuscitation, and they often can be reduced after adequate fluid resuscitation." — Goldman-Cecil Medicine
Why Dopamine Specifically (Not Just Any Vasopressor)
Dopamine's β₁ effects (↑ contractility, ↑ HR) are particularly dependent on adequate preload because you need volume in the ventricle to benefit from increased contractility. If the left ventricle is volume-depleted, increasing contractility only "squeezes an empty bag" — cardiac output does not rise meaningfully.
Additionally, dopamine has a short half-life (~2 minutes), meaning it requires continuous IV infusion with a stable IV access route — which also reinforces the need for reliable IV access and concurrent fluid support.
Summary
| Without IV Fluid | With IV Fluid |
|---|---|
| Inadequate preload → dopamine cannot raise CO | Adequate preload → dopamine effectively ↑ CO and BP |
| Risk of organ ischemia from vasoconstriction on empty vessels | Organ perfusion restored |
| High vasopressor doses needed | Lower doses often sufficient after fluid resuscitation |
| Worsening metabolic acidosis | Improved lactate clearance |
IV fluid and dopamine are complementary, not competing strategies — fluid restores the volume deficit while dopamine supports vascular tone and cardiac output during and after resuscitation.
Sources: Goldman-Cecil Medicine (2-Volume Set), pp. 1077–1078; Tintinalli's Emergency Medicine, p. 175; Schwartz's Principles of Surgery, 11th Ed.
isnt dopamine a catecholamine
Yes, dopamine is a catecholamine. The previous answer already stated this — Tintinalli's describes it as "an endogenous catecholamine and a metabolic precursor of norepinephrine and epinephrine."
The catecholamine family includes:
| Compound | Endogenous? | Role |
|---|---|---|
| Dopamine | Yes | Neurotransmitter; precursor to NE |
| Norepinephrine (NE) | Yes | Sympathetic neurotransmitter; vasopressor |
| Epinephrine | Yes | Adrenal medulla hormone; fight-or-flight |
| Dobutamine | Synthetic | Inotrope (structurally catecholamine-like) |
All catecholamines share the same core structure: a catechol ring (benzene ring with two hydroxyl groups) plus an amine side chain. Dopamine sits at the beginning of the biosynthetic pathway:
Tyrosine → L-DOPA → Dopamine → Norepinephrine → Epinephrine
When used pharmacologically in shock, dopamine functions as an exogenous catecholamine — it stimulates adrenergic and dopaminergic receptors just as endogenous catecholamines do, but with dose-dependent receptor selectivity that makes it clinically distinct from norepinephrine or epinephrine.
its good for renal function also icreases bp then why do we choose ad over dopamine
Finding Sources
Searching PubMed
norepinephrine dopamine septic shock mortality
Finding Sources
Reading Article
I now have everything needed. Here's the full answer:
Why Norepinephrine (Adrenaline/NA) is Chosen Over Dopamine
You're right that dopamine was historically attractive because it was believed to:
- Protect renal function at low doses
- Increase BP at higher doses
- Be a "gentle" catecholamine
But clinical evidence dismantled both of those assumptions. Here's why norepinephrine won:
1. The "Renal Protection" of Dopamine is a Myth
Low-dose dopamine (1–5 µg/kg/min) does increase renal blood flow and urine output in healthy subjects. But urine output ≠ renal function preservation.
Multiple trials showed low-dose dopamine:
- Does NOT prevent acute kidney injury
- Does NOT reduce need for dialysis
- Does NOT improve renal outcomes
Tintinalli's states directly:
"Low-dose dopamine is no longer recommended for renal protection due to lack of patient outcome evidence." — Tintinalli's Emergency Medicine, p. 175
The increased urine output was a pharmacological effect (dilating afferent arterioles), not actual nephroprotection. Patients still developed AKI at the same rate.
2. Dopamine Causes Far More Arrhythmias
This is the most clinically decisive reason. The landmark De Backer et al. RCT (NEJM 2010) — 1,679 patients, multicenter — directly compared dopamine vs. norepinephrine:
| Outcome | Dopamine | Norepinephrine |
|---|---|---|
| 28-day mortality | 52.5% | 48.5% (NS, p=0.10) |
| Arrhythmic events | 24.1% | 12.4% (p<0.001) |
| Cardiogenic shock mortality | ↑ significantly | Lower |
Dopamine caused nearly double the arrhythmia rate — mostly atrial fibrillation and tachycardia. This is because dopamine's β₁ stimulation increases heart rate and myocardial excitability unpredictably, especially in sick hearts.
"Surviving Sepsis Campaign guidelines no longer recommend dopamine as an initial vasopressor for septic shock, based on data showing lower short-term mortality and decreased incidence of tachyarrhythmias in patients receiving norepinephrine versus dopamine." — Tintinalli's Emergency Medicine
3. Norepinephrine Has More Predictable, Balanced Effects
| Property | Dopamine | Norepinephrine |
|---|---|---|
| Receptor action | α₁, β₁, dopaminergic (dose-dependent, unpredictable) | Strong α₁ + moderate β₁ (consistent) |
| Vasoconstriction | Variable by dose | Reliable, dose-titratable |
| Heart rate | ↑↑ (tachycardia prone) | Minimal ↑ or even reflex ↓ |
| Arrhythmia risk | High | Low |
| Renal protection | Disproven | Not claimed — but MAP restoration protects kidneys |
Goldman-Cecil Medicine explains:
"Norepinephrine is a strong vasoconstrictor with enough beta-adrenergic effects to increase myocardial contractility and to protect the heart against the increased afterload posed by vasoconstriction."
By raising MAP reliably, norepinephrine restores renal perfusion pressure — which is actually what protects the kidney.
4. Dopamine is Worse in Cardiogenic Shock Specifically
The De Backer trial showed dopamine significantly increased mortality in cardiogenic shock patients (p=0.03). The tachycardia it causes increases myocardial oxygen demand in an already-ischemic heart — exactly the wrong effect.
When is Dopamine Still Used?
Dopamine is not completely abandoned. It remains an option in:
- Symptomatic bradycardia unresponsive to atropine (its β₁ chronotropic effect is useful here)
- Patients with absolute or relative bradycardia where tachycardia is acceptable or even desired
- Resource-limited settings where norepinephrine is unavailable
"Dopamine can be considered as an alternative vasopressor only in highly selected patients — i.e., patients with low risk of tachyarrhythmias and absolute or relative bradycardia." — Tintinalli's Emergency Medicine, p. 175
Bottom Line
| Why dopamine seemed good | Why evidence rejected it |
|---|---|
| Renal vasodilation at low dose | No actual AKI prevention in trials |
| Raises BP and CO | So does NE, more reliably and safely |
| Endogenous catecholamine | Also causes dangerous arrhythmias |
| Theoretical renal/splanchnic benefit | Not demonstrated clinically |
The shift to norepinephrine was driven by hard clinical endpoints — arrhythmia rates and mortality — not just theory.
Sources: Tintinalli's Emergency Medicine, p. 175; Goldman-Cecil Medicine, p. 1078; De Backer D et al., NEJM 2010 [PMID: 20200382]
orthostatic htn
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
I have rich content from Harrison's, Goldman-Cecil, and Hurst's Heart. Here is a comprehensive answer covering both entities:
Orthostatic Hypertension vs. Orthostatic Hypotension — Clarification First
"Orthostatic HTN" could mean two things:
| Term | Definition |
|---|---|
| Orthostatic Hypotension (OH) | BP drops on standing — the far more common clinical entity |
| Orthostatic Hypertension | BP rises paradoxically on standing — a less common but real phenomenon |
I'll cover both, starting with OH since it is what is usually meant clinically.
Orthostatic Hypotension (OH)
Definition
Classical OH: sustained reduction of SBP ≥20 mmHg or DBP ≥10 mmHg within 3 minutes of active standing or head-up tilt ≥60°.
In hypertensive patients the threshold is higher: ≥30/15 mmHg drop.
— Harrison's Principles of Internal Medicine, 22nd Ed.
Normal Physiology on Standing
When you stand up, ~500–700 mL of blood pools in the lower limbs and splanchnic bed, reducing venous return. Normally this triggers:
- Baroreceptor activation
- Sympathetic outflow → ↑ HR + peripheral vasoconstriction
- BP is maintained or slightly rises
OH occurs when this compensatory response fails.
Causes
Neurogenic OH (NOH) — autonomic nervous system failure:
- Parkinson's disease / multiple system atrophy
- Diabetic autonomic neuropathy
- Pure autonomic failure
- Amyloidosis, autoimmune autonomic ganglionopathy
Key clue: In NOH, the compensatory HR increase is blunted (<15 bpm). A ΔHR/ΔSBP ratio <0.5 beats/min/mmHg confirms NOH. These patients have the worst prognosis — 44% mortality over 30 months, >60% over 10 years (Harrison's).
Non-neurogenic OH — compensatory HR increase >15 bpm (heart is trying but something else is wrong):
| Category | Examples |
|---|---|
| Volume depletion | Dehydration, hemorrhage, Addison's disease |
| Cardiac | Heart failure, arrhythmia, constrictive pericarditis |
| Drugs | Antihypertensives, α-blockers, diuretics, tricyclics, levodopa, alcohol |
| Prolonged bed rest | Deconditioning |
Symptoms
- Lightheadedness, dizziness on standing (most common)
- Pre-syncope or syncope
- Visual blurring ("greyout")
- Neck/shoulder/occipital pain on standing (coat-hanger distribution) — relieved by lying down
- Fatigue, cognitive slowing
- Worsened by: meals, heat, exercise, alcohol, large meals
Prevalence
- <5% under age 50
- Up to 20% over age 70
- Associated with increased risk of falls, stroke, heart failure, and death
Management
Goal: Relieve symptoms, not achieve a target BP.
Step 1 — Remove aggravating factors:
- Withdraw/reduce offending drugs (antihypertensives, diuretics, α-blockers)
- Adjust levodopa dosing in Parkinson's patients
Step 2 — Non-pharmacologic:
- Rise slowly, sit briefly before standing
- Avoid Valsalva maneuvers
- Avoid hot environments (cause vasodilation)
- Physical countermaneuvers: leg crossing, squatting, buttock clenching, toe-rising
- Compression stockings (≥15–20 mmHg) or abdominal binder
- Fluid intake 2–2.5 L/day + increase salt intake (1–2 tsp/day)
- Bolus water drinking (500 mL) — produces rapid BP rise within 5–10 min via portal osmoreceptors
- Small, low-carbohydrate meals (prevent postprandial hypotension)
- Exercise in recumbent/seated position or swimming
Step 3 — Pharmacologic:
| Drug | Mechanism | Dose |
|---|---|---|
| Fludrocortisone | Mineralocorticoid → ↑ renal Na/water reabsorption → expands volume | 0.1 mg/day |
| Midodrine | Selective α₁ agonist → arterial + venous constriction | 5–10 mg TID |
| Droxidopa | Converted to norepinephrine peripherally | 100–600 mg TID |
| Atomoxetine | NE reuptake inhibitor → ↑ NE at neurovascular junction | 10–18 mg BD |
| Pyridostigmine | Acetylcholinesterase inhibitor → ↑ ganglionic transmission | 30–60 mg TID |
Midodrine or droxidopa should be taken before getting out of bed and no later than 3–4 hours before bedtime — to avoid supine hypertension. — Goldman-Cecil Medicine
Orthostatic Hypertension
This is a paradoxical rise in BP upon standing — less common but clinically important.
Definition: SBP rise ≥20 mmHg on standing (no universal consensus threshold).
Mechanism: Seen in autonomic failure syndromes (especially diabetics) where the normal vasodilatory response to the supine position is lost — so BP remains elevated upright. Upright catecholamine levels are often markedly elevated (>600 mg/dL).
"A subgroup of patients with autonomic failure — especially diabetic patients — have a combination of supine hypertension and orthostatic hypertension, caused by failure to properly vasoconstrict when upright or vasodilate when supine." — Hurst's The Heart, 15th Ed.
Clinical significance:
- Paradoxically coexists with OH in the same patient
- Supine hypertension at night + orthostatic hypotension during the day = very difficult to manage
- Treating supine hypertension can worsen OH; treating OH can worsen supine hypertension
Key Clinical Pearl: OH + Supine Hypertension Paradox
Many patients with autonomic failure (especially Parkinson's, MSA, diabetic neuropathy) have:
- Daytime: OH (BP drops on standing → syncope risk)
- Nighttime/supine: Hypertension (BP rises → cardiovascular end-organ damage risk)
This is because baroreflexes are impaired in both directions — the body can neither maintain BP upright nor dampen it supine.
Treatment is a balancing act: short-acting antihypertensives at bedtime (e.g., nitroglycerine patch removed on waking) + vasopressor support during the day.
Sources: Harrison's Principles of Internal Medicine 22nd Ed., p. 3590; Goldman-Cecil Medicine, p. 386; Hurst's The Heart 15th Ed., p. 1309
postural hypertension
Finding Sources
Finding Sources
You've run out of free credits. Sign up for a free account to continue using Orris.
This is a shared conversation. Sign in to Orris to start your own chat.